Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sensory testing evaluation of Halneuron (tetrodotoxin) in healthy adults
NL-OMON60699Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tetrodotoxin (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Change from baseline in individual QST sensory measurements at 1 hour post-dose. Started Aug 2023; status: completed.
02
Drugs
tetrodotoxin
Beyond the preview
Go deeper on NL-OMON60699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60699.